Related Experiment Video
Updated: Jul 26, 2026
04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
More and earlier surfactant for preterm infants
J L Hughes1, E McCall, F Alderdice
1Department of Child Health, Queen's University Belfast, Institute of Clinical Science, North Ireland, UK.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|February 24, 2006
Summary
Surfactant administration for premature infants (less than 32 weeks gestation) significantly increased, especially within one hour of birth. Regional feedback facilitated this quality improvement in neonatal care.
Area of Science:
- Neonatal Medicine
- Pediatric Respiratory Care
- Quality Improvement in Healthcare
Background:
- Premature infants (less than 32 weeks gestation) often require surfactant replacement therapy.
- Optimal timing for surfactant administration is crucial for respiratory outcomes.
- Evidence-based guidelines recommend timely surfactant delivery.
Purpose of the Study:
- To evaluate changes in surfactant administration practices for preterm infants.
- To assess the impact of regional data collection and feedback on clinical practice.
- To determine if surfactant administration timeliness improved over two distinct periods.
Main Methods:
- Comparative analysis of surfactant administration rates.
- Data collected from two distinct time periods: 1994-1996 and 1999-2001.
- Focus on infants born at less than 32 weeks gestation.
Main Results:
- Overall surfactant administration increased from 41% to 54%.
- Administration within one hour of birth saw a substantial rise from 13% to 60%.
- Regional data collection and feedback were associated with improved adherence to guidelines.
Conclusions:
- Significant improvements in surfactant administration rates were observed.
- Timely surfactant delivery, particularly within the first hour, markedly improved.
- Regional quality improvement initiatives are effective in promoting evidence-based neonatal care.
More Related Videos
Related Concept Videos
01:05Breathing
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:19Factors Affecting Pulmonary Ventilation
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...